Future vs Cardinal Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
Future pairs members with 130+ expert human coaches at $199/month using Apple Watch biometrics; 4.9-star rated app with $108M raised ($75M Series C). Founded 2017, San Francisco.
About
Future was founded in 2017 in San Francisco with the mission of making expert personal training accessible to anyone, not just athletes or the wealthy who can afford in-person coaching. The company built a digital personal training platform that pairs each member with a dedicated human coach who designs individualized workout plans, monitors progress through Apple Watch biometric data, and provides real-time feedback through the app. Future's core philosophy is that accountability and personalization — not generic content — are what actually drive sustained behavior change and fitness results.\n\nFuture's platform pairs members with more than 130 expert coaches who have backgrounds in strength and conditioning, sports performance, and clinical exercise science. Coaches review member activity daily, adjust programming based on recovery and performance data, and communicate directly through the app — creating a relationship-driven coaching model at digital scale. The service is priced at $199 per month, positioning it as a premium alternative to both in-person personal training and algorithm-driven fitness apps. Future integrates deeply with Apple Watch to capture heart rate, workout metrics, and activity data, giving coaches objective performance signals to inform programming decisions.\n\nFuture has raised $108 million in total, including a $75 million Series C, and maintains a 4.9-star rating in the App Store across tens of thousands of reviews — a remarkable signal of member satisfaction in a category often plagued by high churn. The company's human-plus-AI coaching model occupies a distinct position between the low-cost digital fitness market and the high-cost in-person coaching market, and its 130-plus coach network gives it a proprietary talent asset that is difficult to replicate. As demand for personalized health and longevity programs grows among high-income professionals, Future's model scales coach capacity through AI-assisted tools while preserving the relational quality that drives retention.
Dublin OH pharmaceutical distribution (NYSE: CAH) $230B+ revenue; specialty pharma GLP-1 distribution tailwind, at-Home Solutions growth, medical divestiture to Medline competing with McKesson and Cencora.
About
Cardinal Health, Inc. is a Dublin, Ohio-based healthcare distribution and medical products company — publicly traded on the New York Stock Exchange (NYSE: CAH) as an S&P 500 Health Care component — distributing pharmaceutical products to pharmacies, hospitals, and healthcare providers, and manufacturing and distributing medical and surgical supplies through approximately 44,000 employees. In fiscal year 2025 (ending June 2025), Cardinal Health generated revenues exceeding $230 billion in its Pharmaceutical and Specialty Solutions segment — reflecting the company's role as a pass-through distributor of branded and generic pharmaceuticals at near-zero margin on drug cost, where Cardinal Health earns distribution fees and rebate income on enormous volumes. CEO Jason Hollar has executed a two-segment strategy focused on optimizing pharmaceutical distribution (Pharmaceutical and Specialty Solutions — $227B+ revenue at low margin) and growing medical products profitability (Global Medical Products and Distribution — higher-margin branded surgical products, Cardinal Health brand commodities, and at-Home Solutions). The 2024 divestiture of the medical segment's Cardinal Health Brand product line to Medline Industries for $1.1 billion simplified the medical segment focus toward specialty distribution and home healthcare supply. Cardinal Health's specialty pharmaceutical distribution (oncology, rheumatology, rare disease biologics through Cardinal Health Specialty Solutions) is a growing higher-margin subsegment as pharmaceutical manufacturers contract with specialty distributors for controlled dispensing of limited-distribution drugs.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.